Comment on CMS-2026-1255-0001
National Health Law ProgramSupportAdvocacy
Summary: The National Health Law Program (NHeLP) supports the proposed rule to increase transparency and accountability in prior authorization for prescription drugs. They urge HHS to strengthen reporting requirements, provide detailed notice of denials at the point of sale, and ensure that prior authorization timeframes for bundled services align with statutory requirements to protect patient access to care.
See attached